Displaying 1 - 12 of 34
Metabolism, Alcohol & Toxicity
1

Novo Nordisk: "Walking the clinical care pathway for NASH: learnings from implementation" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Takeda: "Alpha-1 antitrypsin deficiency (AATD) - Associated liver disease: More common than you may think" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Madrigal Pharmaceuticals: "Emerging role of the hepatic thyroid pathway in the pathophysiology of NASH" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
1

Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Madrigal Pharmaceuticals: "Emerging role of the hepatic thyroid pathway in the pathophysiology of NASH" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Madrigal Pharmaceuticals: "Emerging role of the hepatic thyroid pathway in the pathophysiology of NASH" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Madrigal Pharmaceuticals: "Emerging role of the hepatic thyroid pathway in the pathophysiology of NASH" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Madrigal Pharmaceuticals: "Emerging role of the hepatic thyroid pathway in the pathophysiology of NASH" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Madrigal Pharmaceuticals: "Emerging role of the hepatic thyroid pathway in the pathophysiology of NASH" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" - EASL Congress 2023

View
Displaying 1 - 12 of 34